Evidence check: CRP Entzündung in the context of menopause

CRP (C-reactive protein) is a well-established but non-specific marker of inflammation. During menopause, CRP levels tend to rise, likely due to estrogen decline which promotes pro-inflammatory cytokine activity. Evidence comes mainly from observational studies (e.g., SWAN study) showing a moderate but consistent association. However, CRP alone cannot diagnose menopause or its complications; it is influenced by many factors (infection, stress, obesity). MyBody-X offers CRP measurement as part of its blood tests, but these are marketed as self-tests for lifestyle insights, not medical diagnostics. For clinical interpretation of CRP in menopause, a physician should be consulted, especially to assess cardiovascular risk. Caveat: single measurements have limited value; trends and full risk profile matter. The evidence for routine CRP screening in menopause is moderate – no RCTs prove that CRP-guided interventions improve long-term outcomes.